Biomedical Engineering Reference
In-Depth Information
Root M, Smith T. Prescribe by risk: the utility of a biomarker-based risk calculation in disease
management to prevent heart disease. Dis Manag 2005;8:106-13.
Sabatine MS, Liu E, Morrow DA, et al. Metabolomic identification of novel biomarkers of myo-
cardial ischemia. Circulation 2005;112:3868-75.
Sechtem U, Mahrholdt H, Vogelsberg H. Cardiac magnetic resonance in myocardial disease. Heart
2007;93:1520-7.
Sharma JN. Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system. Arch
Med Res 2006;37:299-306.
Shaw SY. Molecular imaging in cardiovascular disease: targets and opportunities. Nat Rev Cardiol
2009;6:569-79.
Shiffman D, Chasman DI, Zee RY, et al. A kinesin family member 6 variant is associated with
coronary heart disease in the Women's Health Study. J Am Coll Cardiol 2008;51:444-8.
Silver MA. The natriuretic peptide system: kidney and cardiovascular effects. Curr Opin Nephrol
Hypertens 2006;15:14-21.
Sudhir K. Clinical review: Lipoprotein-associated phospholipase A2, a novel inflammatory
biomarker and independent risk predictor for cardiovascular disease. J Clin Endocrinol Metab
2005;90:3100-5.
Tabibiazar R, Wagner RA, Deng A, et al. Proteomic profiles of serum inflammatory markers
accurately predict atherosclerosis in mice. Physiol Genomics 2006;25:194-202.
Vaisar T, Mayer P, Nilsson E, et al. HDL in humans with cardiovascular disease exhibits a pro-
teomic signature. Clin Chim Acta 2010;411:972-9.
van Kimmenade RR, Januzzi JL, Ellinor PT, et al. Utility of Amino-Terminal Pro-Brain Natriuretic
Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure. J Am
Coll Cardiol 2006;48:1217-1224.
Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardio-
vascular events and death. N Engl J Med 2006;355:2631-9.
Weber M, Hamm C. Redefinition of myocardial infarction--relevance of biomarkers. Herz
2008;33:115-21.
Weikert C, Stefan N, Schulze MB, et al. Plasma fetuin-a levels and the risk of myocardial infarc-
tion and ischemic stroke. Circulation 2008;118:2555-62.
Zethelius B, Berglund L, Sundström J, et al. Use of Multiple Biomarkers to Improve the Prediction
of Death from Cardiovascular Causes. NEJM 2008;358:2107-2116.
Search WWH ::
Custom Search